InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
InDevR Raises $9 Million in Series B Financing and Partners [...]
InDevR Raises $9 Million in Series B Financing and Partners [...]
[Press Release] InDevR launches a new product that could shave weeks [...]
InDevR plans to launch a Research Use Only version of [...]
I&L showcased InDevR products at the World Vaccine Congress in [...]
InDevR licenses Mount Sinai influenza antibodies for VaxArray neuraminidase potency [...]
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.